183 related articles for article (PubMed ID: 35578666)
1. Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.
Zhang J; Huang J; Liu W; Ding L; Cheng D; Xiao H
J Immunol Res; 2022; 2022():3655908. PubMed ID: 35578666
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
[TBL] [Abstract][Full Text] [Related]
3. Identification of key genes and pathways in Ewing's sarcoma using bioinformatics analysis.
Yan C; Wang Y; Wang Q; Feng X; Wang L; Bu Z; Lu B; Jiang J
J BUON; 2018; 23(5):1472-1480. PubMed ID: 30570875
[TBL] [Abstract][Full Text] [Related]
4. [Bioinformatics-based identification of key genes CDC5L and related pathways in osteosarcoma and Ewing's sarcoma].
Feng N; Song WX; Shao LP; Gao YH; Zhao CW
Zhongguo Gu Shang; 2022 Mar; 35(3):276-80. PubMed ID: 35322620
[TBL] [Abstract][Full Text] [Related]
5. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
6. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
7. Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing's sarcoma.
Shi X; Wu Y; Tang L; Ni H; Xu Y
Aging (Albany NY); 2023 Mar; 15(6):2321-2346. PubMed ID: 36988561
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
9. Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma.
Liao H; Xie X; Xu Y; Huang G
Onco Targets Ther; 2018; 11():6947-6956. PubMed ID: 30410352
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis of ZBTB16 as a Prognostic Marker for Ewing's Sarcoma.
Ding K; Qiu W; Yu D; Ma H; Xie K; Luo F; Li S; Li Z; Wei J
Biomed Res Int; 2021; 2021():1989917. PubMed ID: 34660783
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma.
Lollini PL; Palmieri G; De Giovanni C; Landuzzi L; Nicoletti G; Rossi I; Griffoni C; Frabetti F; Scotlandi K; Benini S; Baldini N; Santoni A; Nanni P
Int J Cancer; 1997 May; 71(5):732-6. PubMed ID: 9180138
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
Scotlandi K; Perdichizzi S; Manara MC; Serra M; Benini S; Cerisano V; Strammiello R; Mercuri M; Reverter-Branchat G; Faircloth G; D'Incalci M; Picci P
Clin Cancer Res; 2002 Dec; 8(12):3893-903. PubMed ID: 12473605
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.
Lu Q; Lu M; Li D; Zhang S
Mol Med Rep; 2018 Oct; 18(4):3577-3588. PubMed ID: 30106161
[TBL] [Abstract][Full Text] [Related]
15. Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma.
Miller BJ; Lynch CF; Buckwalter JA
Clin Orthop Relat Res; 2013 Nov; 471(11):3398-404. PubMed ID: 23821136
[TBL] [Abstract][Full Text] [Related]
16. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of Ewing's sarcoma: Seeking key candidate genes and pathways.
Zhang J; Zhang Y; Li Z; Wu H; Xun J; Feng H
Oncol Lett; 2019 Dec; 18(6):6008-6016. PubMed ID: 31788075
[TBL] [Abstract][Full Text] [Related]
18. Sequential Ewing's sarcoma and osteosarcoma.
Sharma V; Crawford AH; Evans J; Collins MH
J Pediatr Orthop B; 2008 Nov; 17(6):333-7. PubMed ID: 18841070
[TBL] [Abstract][Full Text] [Related]
19. TIPE1 inhibits the growth of Ewing's sarcoma cells by suppressing Wnt/β-catenin signaling.
Wang Z; Sun L; Liu S; Jiang H
Clin Transl Oncol; 2023 May; 25(5):1332-1339. PubMed ID: 36495466
[TBL] [Abstract][Full Text] [Related]
20. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
